The issue is how much demand there is for longer-term paper, which will be auctioned tomorrow, including 3-year and 10-year paper. Italian 10-year yields are down to 6.85 percent about 15 basis points below yesterday (Tuesday).
NBC's Miguel Almaguer with the latest details on a bizarre death at the home of a pharmaceutical CEO.
The six-year-old son and the 32-year-old girlfriend of a prominent pharmaceutical executive have each died in a span of less than a week, and both deaths were tied to his historic mansion on the San Diego Bay.
CNBC's Jane Wells with the latest details on the tragic death of the girlfriend of Medicis founder, Jonah Shacknai.
Stocks finished lower Thursday for the fourth session in five after Bernanke said the Fed is not prepared to take further action and amid ongoing concerns about the U.S. debt ceiling, erasing earlier gains fueled by encouraging economic news as well as strong earnings from JPMorgan.
Stocks declined Thursday after Bernanke said the Federal Reserve is not prepared to take further action on the economy and amid ongoing concerns about the U.S. debt ceiling.
Plus, his calls on The Hain Celestial Group and Hudson City Bancorp.
There are three things the famed strategist doesn't like about this market right now.
Vice or not, this terrible habit’s worth trading.
In good times or bad, for the most part, they work.
Vanity can drive profits as much as anything else. With that in mind, get the latest on the cosmetic pharmaceuticals business from Medicis CEO John Shacknai.
Here's what analysts and others say they're watching before the bell Tuesday.
Here's what analysts and others say they're watching before the bell Wednesday.
In celebration of NBC Universal’s Healthy Week, Fast Money put together a few ideas for you. After all, it’s our goal to keep you healthy, wealthy and wise.
Cramer talked with the Medicis CEO about his company's newest product.
CEO David Pyott tells investors to think of more than just Botox when his company is mentioned.
Medicis Pharma could have such a product on the market by 2011.
Stocks closed mixed Friday amid heavy selling in financial and retail stocks.
Shares of Allergan are taking a big hit today after the Food and Drug Administration announced it's putting out an "Early Communication" (Translation: We're reviewing some reports of adverse events, but in the meantime, doctors and patients should be vigilant) regarding potentially fatal side effects of the popular muscle relaxant Botox.
Stocks waffled Friday amid more turmoil for bond insurers and a statement from a Federal Reserve official that a recession may be unavoidable.